BIIB - Company ID 0000875045
BIOGEN INC. (BIIB) reported net income of $1.29B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $1.29B | -20.8% |
| FY 2024 | $1.63B | +40.6% |
| FY 2023 | $1.16B | -61.9% |
| FY 2022 | $3.05B | +95.8% |
| FY 2021 | $1.56B | -61.1% |
| FY 2020 | $4.00B | -32.1% |
| FY 2019 | $5.89B | +32.9% |
| FY 2018 | $4.43B | +74.5% |
| FY 2017 |
BIOGEN INC. (BIIB) reported net income of $1.29B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, BIOGEN INC.'s net income grew from $1.23B to $1.29B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.54B |
| -31.4% |
| FY 2016 | $3.70B | +4.4% |
| FY 2015 | $3.55B | +20.9% |
| FY 2014 | $2.93B | +57.6% |
| FY 2013 | $1.86B | +34.9% |
| FY 2012 | $1.38B | +11.8% |
| FY 2011 | $1.23B | - |